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Abstract
Background: Back, neck and shoulder pain are the most common causes of occupational disability. They reduce
health-related quality of life and have a significant economic impact. Many different forms of physical treatment are
routinely used. The objective of this study was to estimate the cost of physical treatments which, despite the absence
of evidence supporting their effectiveness, were used between 2004 and 2007 for chronic and non-specific neck pain
(NP), back pain (BP) and shoulder pain (SP), within the Spanish National Health Service in the Canary Islands (SNHSCI).
Methods: Chronic patients referred from the SNHSCI to private physical therapy centres for NP, BP or SP, between
2004 and 2007, were identified. The cost of providing physical therapies to these patients was estimated.
Systematic reviews (SRs) and clinical practice guidelines (CPGs) for NP, BP and SP available in the same period were
searched for and rated according to the Oxman and AGREE criteria, respectively. Those rated positively for ≥70% of
the criteria, were used to categorise physical therapies as Effective; Ineffective; Inconclusive; and Insufficiently
Assessed. The main outcome was the cost of physical therapies included in each of these categories.
Results: 8,308 chronic cases of NP, 4,693 of BP and 5,035 of SP, were included in this study. Among prescribed
treatments, 39.88% were considered Effective (physical exercise and manual therapy with mobilization); 23.06%
Ineffective; 13.38% Inconclusive, and 23.66% Insufficiently Assessed. The total cost of treatments was € 5,107,720.
Effective therapies accounted for € 2,069,932.
Conclusions: Sixty percent of the resources allocated by the SNHSCI to fund physical treatment for NP, BP and SP
in private practices are spent on forms of treatment proven to be ineffective, or for which there is no evidence of
effectiveness.
Keywords: Physical therapy, Treatment costs, Evidence based practice, Avoidable costs, Back pain, Neck pain,
Shoulder pain
Background
Back, neck and shoulder problems are the most com-
mon causes of pain and occupational disability [1-3].
They reduce health-related q u a l i t yo fl i f e( H R Q L )a n d
have a significant economic impact [4-8]. These muscu-
loskeletal disorders are usually non-specific, which
means that pain cannot be attributed to any specific
structural cause and is believed to originate from soft
tissues [9]. Their lifetime prevalence is 50-70% and they
are among the most common reasons for primary care
visits in Spain [10-14].
The Spanish National Health Service is a public health
insurance system with universal coverage which provides
free health care to every resident in Spain. Within the
Spanish National Health Service (SNHS), primary care
practices and hospitals are owned and managed by the
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practices which are owned and managed by private enti-
ties exist in parallel to the SNHS, and operate indepen-
dently. In 2008, 72.5% of total health care expenditure
in Spain came from governmental funding [15]. The
SNHS can choose to refer patients to private practices
in order to shorten waiting times, usually for non-
urgent, non life-threatening conditions, such as physical
therapy for musculoskeletal complaints, or surgery for
cataract or abdominal hernia. In such cases, the SNHS
fully covers the cost of procedures performed by the pri-
vate practices on the patients it refers. The SNHS is
m a n a g e da tt h er e g i o n a ll e vel, and fully financed by
national taxes, although some regional governments add
local taxes to provide additional funding. The Spanish
National Health Service in the Canary Islands (SNHSCI)
covers a population of two million individuals, and out-
sources approximately 70% of physical treatments to the
private sector. Physicians at the SNHSCI make the diag-
nosis and treatment recommendations, but clinicians
employed by the private practices have the ability to
adjust or change treatments according to each patient’s
clinical response. The clinical management of shoulder,
neck or back pain is not regulated by compulsory clini-
cal guidelines, and clinicians are free to choose whether
or not to follow the European and Spanish evidence-
based clinical guidelines for low back pain [16,17].
Many different forms of physical treatment are routi-
nely provided within the SNHS. The objectives of this
study were to: a) identify the forms of physical therapies
used for treating chronic non-specific neck (NP), back
(BP) and shoulder pain (SP) between 2004 and 2007,
within routine practice in the SNHSCI; b) classify these
forms of treatments according to evidence on their
effectiveness available at the time; and c) estimate the
cost of physical treatments which had either been pro-
ven ineffective or not shown to be effective.
Methods
Identification of the forms of physical treatments used
The Information System for private Hospital contracts
(ISHC), is a governmental database which includes data
from patients in the SNHSCI, who were referred to pri-
vate practices. In the case of patients with musculoskele-
tal problems who are referred for physical therapy, the
database gathers demographic data, patient’s diagnosis
(ICD-9-CM) and the type and number of physical thera-
pies received.
In Spain, occupational diseases and work-related inju-
ries are not managed by the National Health Service,
but by separate workers’ compensation institutions. As a
result, occupational diseases and work-related injuries
are not included in the ISHC.
The type and number of physical treatments funded
by the SNHSCI from January 1st, 2004 to December
31st, 2007, for patients over 18 years for non-specific
chronic NP, BP and SP (ICD-9-CM-723.1, ICD-9-CM-
724.2 and ICD-9-CM-726.1) were identified using the
ISHC database. Chronic NP, BP or SP was defined as an
episode lasting 12 or more weeks [18]. Only patients
who initiated treatment at least 12 weeks after seeking
care for SP, NP or BP (i.e., chronic cases) were included
in the study. Treatments for other conditions were not
considered.
The unit of analysis was every case of non-specific
chronic NP, BP and SP identified in the ISHC database,
irrespectively of whether a single patient received treat-
ment on several occasions for the same or different con-
ditions during the study period.
Evidence on the effectiveness of the different forms of
physical treatment
An electronic search of clinical practice guidelines
(CPGs) and systematic reviews (SRs) on NP, BP and SP
published before 31st of December, 2007, was carried
out in the following databases: MEDLINE, EMBASE,
The Centre for Reviews and Dissemination (University
of York), Cochrane Library Plus, Trip Database, Pubgle,
The National Guideline Clearinghouse, Fisterra, Guiasa-
lud, The Web of the Back (Kovacs Foundation), The
European Commission Research Directorate General
(University of Bergen, Norway) and the Institute for
Clinical Systems Improvement (Minnesota, USA) [See
additional file 1: Search strategy].
CPGs and SRs focusing on chronic nonspecific NP, BP
and SP, and covering any form of physical treatment,
were selected. Their quality was assessed independently
by two assessors, and disagreements between them were
discussed and resolved by the first author. Quality
assessment was based on the AGREE instrument for
CPGs and the Oxman scale criteria for SRs. The
AGREE instrument consists of 23 key items organised
in six domains, to capture separate dimensions of CPG
quality [19]. These domains are: scope and purpose, sta-
keholder involvement, rigour of development, clarity
and presentation, applicability, and editorial indepen-
dence. The Oxman scale has been widely used to assess
the quality and reliability of SR. The scale contains ten
items on the internal and external validity of SRs (search
methods, criteria to include studies and avoiding bias,
criteria to assess validity, methods of combination of
study results, quality of reporting and data supporting
conclusions) [20]. Only CPGs and SRs which were posi-
tively rated in ≥ 70% of the dimensions explored by
these instruments were considered of “high quality” and
were included in this study.
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included, physical treatments were classified into four
categories [21]: Effective; of Inconclusive Effectiveness;
Insufficiently assessed and Ineffective. Each form of
treatment was classified in the best category in which
any of the included CPGs or SRs had ranked it. For
instance, it was sufficient for a therapy to be considered
effective in one of the CPGs or SRs included, to be clas-
sified as such in this study. According to this conserva-
tive assumption any form of treatment labelled as
“exercise” was considered to be effective.
Cost estimation
The fees paid by the SNHSCI to private practices cover 35
sessions of physical therapy for SP patients, and 30 for NP
and BP. These fees remain constant irrespectively of the
type of physical treatment actually provided during each
session. In fact, the physicians in private practices can
modify the physical treatment dispensed, depending on
patient’s clinical evolution and their own clinical criteria.
In practice, most patients included in this study actually
received several forms of physical treatment (Table 1).
Since the SNHSCI pays for a “package” of 30-35 sessions,
and the type of physical therapies actually performed dur-
ing these sessions varies from one patient to the other, it
was impossible to estimate the amount paid by the SNHS
for each particular form of physical treatment.
Therefore, the costs were estimated using data provided
by the private subcontractor to which SP, NP and BP
patients were referred from the SNHSCI. These data only
included personnel and equipment costs incurred by the
private practices in order to provide each form of physical
treatment to SP, NP and BP patients referred from the
SNHSCI (Table 1). For treatments which are provided to
several patients simultaneously (e.g., thermotherapy or
some forms of exercise), the conservative assumption that
each group comprised two patients, was made. Therefore,
for such treatments, unit cost per patient was estimated by
dividing the cost of treatment by two.
Total cost for each therapy was obtained by multiply-
ing the unit cost by number of sessions and by number
of patients (Table 1). For example, the costs associated
with exercises for NP patients were obtained as follows:
unit cost per patient per session (€1.25) × number of
sessions per patient (30) × number of different types of
exercises applied (10,440) in all included cases.
Avoidable costs were defined as costs of treatments
which had been classified as “Ineffective”, “of Inconclu-
sive Effectiveness” or “Insufficiently Assessed”. All costs
are expressed in inflation-adjusted, 2008 Euros (€).
Results
From 2004 to 2007, the SNHSCI covered the cost of
physical treatment administered in private practices for
8,308 cases of chronic nonspecific NP, 4,693 of BP and
5,035 of SP. In 1,082 (5.99%) out of these 18,036 cases
were simultaneously suffering from other musculoskele-
tal disorders.
The average age of the patients was 53.85 years (SD:
±14.52) and 73.25% were women. On average, patients
treated for NP, BP and SP received 4.36, 4.35 and 4.52
different forms of physical therapies respectively. The
forms of treatment most commonly administered, its
frequencies and number of sessions are shown in Table
1.
The SR search detected 806 references, corresponding
to 525 original studies. Sixty-three of them were relevant
to this study, and 19 rated positively in ≥70% of the
Oxman criteria [22-40]. The CPG search detected 385
references, corresponding to 234 individual guidelines.
Thirty-four of them were relevant to this study, and 12
rated positively in ≥70% of the AGREE criteria
[16,17,21,41-49].
According to the results and recommendations from
t h e s eS R sa n dC P G se x e r c i s ei se f f e c t i v ef o rN P
[21,23,32,35,41,42,45], BP [16,17,28,31,37,46,47] and SP
[31,32,35,38,44,48,49]. Some SRs an d CPGs also recom-
mend adding manual therapy with mobilization for NP
[34,43,45] and SP [31,48]. All the other forms of physi-
cal treatment are either ineffective, of inconclusive effec-
tiveness, or have not been adequately assessed. Table 2
summarizes the evidence supporting the treatments for
these conditions.
In total, 79,381 treatments were applied; 39.88% were
classified as effective, 23.06% as ineffective, and 13.38%
as of inconclusive effectiveness. The clinical value of the
remaining 23.66% had not been properly assessed (Fig-
ure 1).
Overall, 3,037,788 (59.5%) of the € 5,107,720 spent on
physical treatment for these conditions between 2004
and 2007, was spent on technologies which have proven
to be ineffective, or for which there is no evidence of
effectiveness (Figure 1).
Discussion
These results show that as much as 60% of the
resources spent by the SNHSCI on physical treatments
for non-specific chronic NP, BP and SP between 2004
and 2007, were allocated to treatments that had been
found to be either ineffective or for which there was no
evidence of effectiveness. This means that, in that per-
iod, over 3 million Euros from taxpayers’ contributions
was handed over to private centres which had been
awarded contracts by the government to apply treat-
ments which lacked any evidence of effectiveness, or
which had shown to be ineffective.
This is a very conservative estimation of the total cost,
as it does not factor in data on the costs deriving from
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Page 3 of 10Table 1 Costs of each form of therapy used for treating non-specific chronic neck pain (NP), back pain (BP) and shoulder pain (SP).
NP: 8308 cases BP: 4693 cases SP: 5035 cases Total: 18036 cases
Unit cost
a
(€)
(U)
N° of
Procedures
(P)
N° of
Sessions
(S)
Costs
(€)
(UxPxS)
N° of
Procedures
(P)
N° of
Sessions
(S)
Costs
(€)
(UxPxS)
N° of
Procedures
(P)
N° of
Sessions
(S)
Costs
(€)
(UxPxS)
Total N° of
Procedures
Total Costs
(€)
Exercises 1.25 10440
b 30 391509 6613
b 30 248006 7194
b 35 314729 18036 954243
Manual
mobilization
4.5 7366 30 994379 3500 30 472489 3056 35 481346 13922 1948214
Thermotherapy 2 4392 30 263544 2807 30 168405 1591 35 111394 8791 543344
TENS 1 3885 30 116563 2006 30 60180 2435 35 85219 8326 261963
Ultrasounds 1.25 3386 30 126972 1686 30 63209 2665 35 116574 7736 306754
Hot compresses 1.25 1983 30 74371 1123 30 42130 944 35 41318 4051 157819
Electrical
stimulation
2.5 1857 30 139265 1453 30 108975 1170 35 102340 4479 350579
Traction 1 1230 30 36907 281 30 8432 249 35 8699 1760 54037
Short wave 2.5 948 30 71082 418 30 31363 1594 35 139506 2960 241951
Cutaneous laser 3 311 30 27964 120 30 10772 688 35 72198 1118 110935
Iontophoresis 2.5 216 30 16223 152 30 11420 740 35 64778 1109 92421
Magnetotherapy 3 198 30 17862 270 30 24340 412 35 43255 881 85458
Total 36213 2276642 20430 1249722 22737 1581356 79381 5107720
National Health Service in the Canary Islands (ISCH), 2004 to 2007
aUnit costs 1 session for 1 procedure or case
bNo. of procedures for exercises are higher than the number of cases for NP, BP and SP due to different types of specific exercises prescribed, with additional costs, for the same case.
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0physical treatments administered in public hospitals and
primary care practices run by the SNHSCI; only data
from patients who were referred to private practices
were included, representing 70% of patients receiving
physical treatment for these conditions. In addition, it
was sufficient for a therapy to be considered effective in
a single CPG or SR, to be categorised as such in this
study. Any form of treatment labelled as “exercise” was
considered to be effective, irrespective of the type of
exercise, number of sessions, patients’ compliance or
whether it was administered appropriately or inappro-
priately. Exercise was considered to be effective irrespec-
tively of its effect size, whereas previous studies suggest
that improvements in pain or disability of less than 30%
of baseline value are clinically irrelevant for patients
with NP and BP [50-52]. Moreover, only the provider’s
personnel and equipment costs directly related to physi-
cal therapies used for SP, NP and BP were taken into
account, disregarding other costs (e.g., other provider’s
costs-facilities, financial costs, etc.- and profit), societal
costs (work absenteeism associated with receiving physi-
cal therapy sessions, etc.), costs incurred by patients
(transport, loss of earnings, etc.) and other costs for
other institutions (insurance companies dealing with
work-related accidents, private healthcare, etc.).
All the SRs and CPGs reviewed conclude that the
quality of most clinical trials on physical treatments was
low. The main shortcomings were related to randomiza-
tion process, comparison treatments, masking
Table 2 Classification of physical therapies for neck, back and shoulder pain according to the evidence on
effectiveness from selected systematic reviews (SRs) and clinical practice guidelines (CPGs)
a
Form of
treatment
Neck Pain Back Pain Shoulder Pain
SRs CPGs C† SRs CPGs C SRs CPGs C
E‡ IE§ IA| I¶ R# NR* E IE IA I R NR E IE IA I R NR
Exercises
21, 30,
33
19, 39, 40,
45
E
26, 29,
35
42, 43, 46,
47
E
29, 30, 33,
36
44, 48,
49
E
Manual
mobilization
32 34 41, 45 E
43 28 I
29 48 E
Massage
20 19 IE ND ND ND ND ND ND IA ND ND ND ND ND ND IA
Thermotherapy ND ND ND ND ND ND IA
27,
43
42 IE ND ND ND ND ND ND IA
TENS
22 IE
35,
43
24,
36
42 I ND ND ND ND ND ND IA
Ultrasounds
19 IE
35,
43
42 IE
49 IE
Hot compresses ND ND ND ND ND ND IA
43 42 IE ND ND ND ND ND ND IA
Electrical
stimulation
22 I
35,
43
42 IE ND ND ND ND ND ND IA
Traction
19 IE
35,
43
25 42 I ND ND ND ND ND ND IA
Short wave ND ND ND ND ND ND IA
35,
43
42 IE
37,
38
I
Cutaneous laser
31 I
35,
43
23 42 I
49 IE
Iontophoresis
22 I ND ND ND ND ND ND IA ND ND ND ND ND ND IA
Magnetotherapy
22 I ND ND ND ND ND ND IA ND ND ND ND ND ND IA
aSRs and CPGs are cited by its reference number.
†C Classification in this study. ‡E effective; §IE inconclusive effectiveness; || IA insufficiently assessed, ¶ I ineffective. #R CPGs recommending the use of the
therapy. *NR CPGs not recommending the therapy. ND No data available from SRs or CPGs.
31.38 %
20.2 % 21.28 %  23.66 %
20.45 %
12.13 %
7.71 %
13.38 %
31.6 %
49.18 %
32.36 %
39.88 %
18.47 %
38.63 %
23.06 %
0%
20%
40%
60%
80%
100%
Shoulder Pain Neck Pain Back Pain Global: All 
patients
I
E
IE
IA
333,152.00 € 
432,901.25 €
16.55 % 
447,551.25 €
367,751.50 €
465,276.00 €
1,268,732.00 €
179,417.75 €
363,216.50 €
607,508.25 €
368,299.00 €
76,915.25 €
196,999.25 €
1,405,936.25 €
2,069,932.25 €
703,884.25 € 
927,967.25 € 
Figure 1 Distribution of physical therapies administered
according to the evidence of effectiveness and its
corresponding costs to patients with chronic nonspecific NP,
BP or SP in Spanish National Health Service. Legend: I: Proven
ineffective, E: Proven effective, IE: Inconclusive evidence on
effectiveness, IA: Insufficiently Assessed.
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Page 5 of 10procedures, losses to follow-up and missing data. This is
likely to have led to an overestimation of the effect of
physical treatments considered to be effective [21].
Inconsistencies in the prescription of different forms
of treatments for patients with the same condition, may
be due to the preferences of the different types of clini-
cians involved (primary care, rheumatology, rehabilita-
tion, etc.), and the ready availability of these techniques.
However, there are no validated criteria for selecting
patients for whom a particular physical treatment would
be indicated, or to decide the number of sessions they
would need. In fact, there is even no evidence support-
ing the effectiveness of most of these forms of treatment
or the cost/effectiveness of any of them, alone or in
combination. These facts suggest that there may be
ample room for improving the efficiency of the manage-
ment of these syndromes in the SNHS. Ineffective tech-
nologies expose patients to risks, delays, expectations
and costs which are unjustified [53]. Spending public
f u n d so ns u c hp r o c e d u r e si si n a p p r o p r i a t e ,a n de v e n
more so in a context in which health resources are
limited.
A number of recommendations have been issued
regarding the procedures that health authorities should
follow in order to ensure that the health technologies
they finance are safe, effective and efficient [54]. Imple-
menting these recommendations is likely to improve the
efficacy of treatments and reduce wastage of healthcare
resources, hence increasing the efficiency of available
resources. In the context of an economic crisis, it is
necessary to apply these measures before considering
whether healthcare spending needs to be increased. This
may require communication skills to explain it to clini-
cians, patients and public at large [55].
The search for SRs and CPGs was restricted to the
2003-2007 periods. It is possible that studies published
afterwards may have changed, or will change, the evi-
dence supporting the use of procedures included in this
study. However, this study focused on quantifying the
costs of procedures used in routine practice, despite the
lack of supporting evidence at the time of use. In this
regard, even if the evidence were to change based on
future research, the use of these technologies in the
2004-2007 periods would continue to be inappropriate.
The results of this study illustrate the rationale for
recommending disinvestment in specific health technol-
ogies. Disinvestment refers to the processes of reducing
or discontinuing utilization of selected procedures and
treatments [56]. Proactive disinvestment requires prior
analyses of inappropriate variation in clinical practice,
development of valid CPGs designed to update clini-
cians’ education and practice, adequate information for
patients, in order to improve consumer behaviour, orga-
nisational support within the health services for
implementing these changes, economic incentives for
providers, and incentives for improving the efficiency of
purchasing decisions, including the elimination of fund-
ing for technologies which are ineffective and/or unsafe.
Clinicians, consumers and providers of potentially dis-
carded technologies may feel threatened by disinvest-
ment, while beneficiaries, such as taxpayers and patients
themselves, may be less aware of the advantages of such
decisions. As a result, incentives to perpetuate the status
quo may override the call for change [57].
However, disinvestment in technologies which are not
evidence-based, would make funds available for imple-
menting technologies which are not currently available
in the SNHSCI despite having proven effective and cost/
effective for NP and BP within the SNHS, such as
neuro-reflexotherapy [58-60], and for further expanding
the use of technologies proven effective for the condi-
tions reviewed in this study, such as exercise (Table 1,
Figure 1). Funds made available through disinvestment
could also be used for supporting further research on
the effectiveness and cost/effectiveness of physical pro-
cedures, which is sparse and of low scientific validity
(Table 2).
In fact, results from this study suggest that there is a
need for high-quality studies assessing the effectiveness
and cost/effectiveness of different forms of physical
therapy, individually and in combination. These should
be randomized controlled clinical trials, with homoge-
nous and sufficiently large samples, in which validated
instruments should be used to assess clinically mean-
ingful variables, and in which randomization, patients’
assessment and data analysis should be masked. These
trials should analyze both the statistical significance
and clinical relevance of results. Since data on com-
parative effectiveness of different procedures are diffi-
cult to interpret when neither has previously shown
superiority versus “sham” or placebo, these studies
should compare different forms of physical treatment
to the appropriate “sham” procedures as well as to
other interventions. Taking into account that some
treatments formerly believed to be useful for patients
with acute BP proved to actually be harmful, when
appropriate, these studies should consider including
groups without any intervention [61]. The assessment
of the results should also be made from the patient’s
point of view [54,62,63].
This study has some strengths. It contributes to the
existing literature on non-adherence to CPGs by
describing its economic consequences. Analyzed data
were obtained through an information system which
gathers information directly from routine clinical prac-
tice, leading to results which are directly applicable.
Moreover, it analyzes data retrospectively, avoiding
potential changes in referral patterns and selection of
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Page 6 of 10treatments which may occur when clinicians feel
observed.
This study also has certain limitations. The Canary
Islands’ ISHC was one of the first health information
systems to be implemented within the Spanish National
Health Service, and it does not gather data on the cri-
teria behind the prescription of any particular form of
treatment. Moreover, it does not record additional treat-
ments which are applied once the prescribed ones have
started to be administered; therefore, patients may have
actually undergone more forms of treatment than those
which were identified in this study. The coding proce-
dure is likely to be accurate, since it determines pay-
ments, but it may be influenced by the experience of the
coders and their interest in administrative and/or clini-
cal details. However, this is the only systematic and vali-
dated mechanism for post-implementation surveillance
of physical therapies within the Spanish National Health
Service.
This study included patients who, in addition to suf-
fering from NP, BP or SP, also presented other conco-
mitant musculoskeletal disorders which might have
required physical treatment. In order to reduce contami-
nation, the forms of physical treatment which were not
used for NP, BP or SP were excluded. Nevertheless, it
could be argued that some of the physical therapies
attributed to the treatment of NP, BP or SP might have
actually been used to treat concomitant conditions, lead-
ing to inappropriate assumptions. However, such co-
morbidity was only present in 6% of cases. Therefore,
we believe that this potential inaccuracy is unlikely to
modify the results significantly.
These results were obtained from a single Spanish
region, so generalisation of these findings should be dis-
cussed. The Canary Islands has a population of approxi-
mately 2 million, and a similar demographic structure,
populations’ age distribution, life expectancy and infant
mortality to the average values of Spain [64]. The
National Health Service in all of the 17 Spanish regions
offers universal coverage and free access to treatments
consistently across regions and includes the same physi-
cal treatments for SP, NP and BP [65]. The ratios of
healthcare resources (professionals, infrastructure and
technological equipment) in the Canary Islands are in
line with the average values in the rest of Spain [66].
Moreover, the structure of healthcare and referral pro-
cess to physical therapies and rehabilitation services is
fairly homogeneous across the country, with a high pro-
portion of services provided by private outpatient clinics
subcontracted by regional health authorities, and the
clinical management of BP patients is consistent across
regions [67]. All this suggests that generalisability of
these results to the rest of the Spanish National Health
Service should not be a major concern.
No studies quantifying the amount of resources poten-
tially wasted on non evidence-based physical therapies
for SP, NP and BP in other countries have been found.
However, approximately 50%, 65% and 94% of phy-
siotherapists in the UK, US and Canada, respectively,
use procedures which were classified in this study as
non-evidence based (Table 2) [68]. In addition, approxi-
mately 55% of primary care practitioners in the US,
recommend those forms of treatment [69]. In fact, only
in the US more than 200 treatments are offered only for
BP, most of which are not evidence-based [70,71]. With
this non-evidence based approach, the cost of health
care provided to low back pain patients in the US
increased by 65% (constant dollars) from 1997 to 2005,
without generating any improvements in outcomes [72].
In contrast to this, in The Netherlands, yearly costs
derived from low back pain represented 1.7% of the
Gross Domestic Product in 1995, and were reduced to
0.9% in 2002 and to 0.6% in 2007. This decrease was
achieved without noticing deterioration in outcomes,
and is attributed to the progressive implementation of
an evidence-based clinical management [8,73]. Although
available data do not reveal the exact amount of poten-
tial savings which could be made in other countries,
results from this study are likely to be generalisable to
other industrialised countries, suggesting that disinvest-
ing in not-evidence based physical therapies for SP, NP
and BP, would reduce costs without worsening patients’
evolution, thus substantially improving efficiency.
This study did not assess actual patient’s outcomes, and
it might be argued that even therapies classified as “inef-
fective” could have some effects which previous clinical
trials failed to detect. However, this study did not have a
control group, and it would be inappropriate to assume
that potential patients’ improvement in routine practice
necessarily corresponds to benefits deriving from the
treatment, as opposed to unspecific factors (such as nat-
ural history or placebo). In fact, this study was not a clini-
cal trial designed to assess the effectiveness of each form
of treatment. It was a study of clinical practice designed
to quantify the resources allocated to physical treatments
which are supported by the existing evidence, and those
which are not. Therefore, it classified the evidence sup-
porting the use of each of treatment, based on the evi-
dence from existing systematic reviews and evidence-
based clinical guidelines. To this purpose, it seems appro-
priate to assume that a potential effect which is small or
uncommon enough to remain undetected in the available
trials, is likely to be clinically irrelevant.
Conclusions
The average physical treatment applied in private prac-
tice to patients with chronic non-specific neck, back and
shoulder pain referred from the Spanish National Health
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Page 7 of 10Service in the Canary Islands, includes 4.5 forms of
treatment applied in 30-35 sessions. Between 2004 and
2007, only 40% of the treatments applied had previously
shown to be effective, namely exercise and mobilization
for certain cases. A conservative estimate suggests that
treatments lacking any evidence of effectiveness repre-
sented 60% of total expenditure and accounted for
approximately 3 million Euros. Over one million Euros
were spent for treatments which had previously been
shown to be ineffective.
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